Eli Lilly and Co.

Lilly eyes more animal-health acquisitions

March 25, 2010
 IBJ Staff and Bloomberg News
Eli Lilly is interested in assets that may be offered for sale as a result of Sanofi-Aventis SA and Merck & Co.'s plan to combine their veterinary units.
More

Lilly sues Hospira over generic version of Gemzar

March 24, 2010
Bloomberg News
Indianapolis-based Eli Lilly and Co. sued rival drugmaker Hospira Inc. to prevent it from selling a generic version of the cancer drug Gemzar before a patent on the medicine expires in 2013.
More

Lilly Endowment's assets drop more than foundation peers

March 24, 2010
Andrea Muirragui Davis
Once the nation’s wealthiest foundation, Indianapolis-based Lilly Endowment now ranks ninth among its grant-making peers. The endowment’s value fell 15 percent last year, to an estimated $4.8 billion.
More

Bill kicks off years of change for local health care players

March 22, 2010
J.K. Wall
Sweeping changes phase in slowly for most, but insurers, hospitals, drug companies, employers, workers, medical device makers and more will eventually feel impact.
More

Lilly sues to block generic of Adcirca lung treatment

March 17, 2010
Bloomberg News
Netherlands-based Synthon Pharmaceuticals is seeking U.S. Food and Drug Administration approval to sell a copy of the medicine.
More

Lilly victim of theft from Connecticut warehouse

March 16, 2010
 IBJ Staff and Associated Press
Pharmaceuticals stolen Sunday morning could be worth up to $75 million.
More

Lilly pays $50M-plus for rights to testosterone lotion

March 16, 2010
Bloomberg News
Indianapolis-based Lilly will pay Acrux of West Melbourne, Australia, a $50 million license fee, plus $3 million when manufacturing assets are transferred, but the deal could be worth millions more.
More

FDA says 'not yet' on Lilly's once-weekly Byetta

March 15, 2010
J.K. Wall
Regulators won't require more time-consuming tests of the drug, but want Eli Lilly and Co. and its partners to clarify labeling, manufacturing processes.
More

Eli Lilly to buy European rights to Pfizer animal products

March 8, 2010
Scott Olson
The acquisition will benefit Elanco, Lilly's animal health division in Greenfield, which has become increasingly important to Lilly as it braces for patent-protection losses.
More

Market surge doesn't lift Lilly EndowmentRestricted Content

March 6, 2010
Kathleen McLaughlin
Lilly Endowment's resistance to diversify its holdings reached a new height last year, as it failed to sell a single share of the underperforming Eli Lilly and Co. stock while the broader market surged.
More

Three Indiana companies among world's most admired

March 5, 2010
Brightpoint, WellPoint and Cummins are recognized by Fortune magazine as being among the best in their industries.
More

Cornelius to retire as Bristol-Myers Squibb CEO

March 3, 2010
 IBJ Staff and Associated Press
The former Guidant Corp. CEO and long-time Eli Lilly exec said he and his family will be returning to Indianapolis.
More

To attack costs, Lilly accelerates R&D

March 3, 2010
J.K. Wall
With President Barack Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep getting higher for Eli Lilly and Co.'s efforts to develop drugs faster and cheaper.
More

Lilly to shift more employees to Covance

February 26, 2010
J.K. Wall
Greenfield Labs operation expects to add 17 Eli Lilly and Co. workers after taking over staff of 264 in 2008 acquisition.
More

Obama health reform plan slaps drugmakers

February 24, 2010
J.K. Wall
Drugmakers, such as Indianapolis-based Eli Lilly and Co., would shoulder $3.3 billion in fees, face ban on pay-for-delay deals with generic competitor.
More

Lilly, Merck, Pfizer starting research center

February 23, 2010
Associated Press
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
More

WellPoint gets tax delay in Obama health plan

February 22, 2010
Bloomberg News
Insurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional funding for expanding Medicaid, under a White House proposal
More

Lilly asks shareholders to lower takeover barrier

February 20, 2010
J.K. Wall
Eli Lilly and Co. directors have recommended that shareholders toss out the drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder mutiny to succeed.
More

Teva gets European OK to sell generic of Lilly's Evista

February 19, 2010
Bloomberg News
Evista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
More

Pfizer's Viagra patent partially rejected in Lilly fight

February 16, 2010
Bloomberg News
The patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn't different enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against Eli Lilly and Co. over its rival Cialis drug.
More

Lilly awards pay increases to top executives

February 8, 2010
Peter Schnitzler, J.K. Wall
Eli Lilly and Co. CEO John Lechleiter's total compensation increased $4.1 million in 2009.
More

Mississippi settles Zyprexa suit against Lilly for over $18M

February 4, 2010
Associated Press
Mississippi will receive $18.5 million from Indianapolis-based drugmaker Eli Lilly and Co. as part of a settlement over claims the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat.
More

Q&A: Dr. Kristine Courtney

February 3, 2010
J.K. Wall
Dr. Kristine Courtney, Eli Lilly and Co.’s senior director of corporate health services, describes how and why the company spent two years making its clinics some of the first to electronically swap patient records with a local hospital database.
More

Lilly shares trade down after fourth-quarter profits falls

January 28, 2010
J.K. Wall
Analysts worry about dive in already paltry sales of new blood thinner Effient
More

Lilly's profits fall, miss analyst expectations

January 28, 2010
J.K. Wall
The Indianapolis-based drugmaker says a weaker dollar depressed earnings in the fourth quarter compared with a year ago.
More
Page  << 11 12 13 14 15 16 17 18 19 20 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. "bike lanes, specialized lighting, decorative signage, public art, grass medians, trees and rain gardens" These are all nice things to have, but can we freaking get the hundreds of potholes all over the city fixed first?!?!?!!?!?!

  2. When a criminal with multiple prior convictions serves five days of a one year sentence and later kills a police officer with a weapon illegally in his posession, residents of Boone County need to pay a tax to drive to work... PERFECT Progressive logic.. If, on the other hand, a fund were to be set up to build more prisons and hire more guards to keep the known criminals off the streets, I'd be the first to contribute.

  3. Not a word about how much the taxpayers will be ripped off on this deal. Crime spirals out of control and the the social problems that cause it go unheeded by an administration that does not give a rats behind about the welfare of our citizens. There is no money for police or plowing snow (remember last winter) or or or or, but spend on a sports complex, and the cash flows out of the taxpayers pockets. This city is SICK

  4. Sounds like a competitor just wanted to cause a problem. I would think as long as they are not "selling" the alcohol to the residents it is no different than if I serve wine to dinner guests. With all the violent crime happening I would think they should turn their attention to real criminals. Let these older residents enjoy what pleasures they can. Then again those boozed up residents may pose a danger to society.

  5. Where did the money go from the 2007 Income tax increase for public safety that the Mayor used to stir opposition and win the election and then failed to repeal (although he promised he would when he was running for election)? Where did the money go from the water utility sale? Where did the money go from the parking meter deal? Why does the money have all these funds for TIF deals and redevelopment of Mass avenue, and subsidy for luxury high rises, parking garages in Broad Ripple, and granola chain grocery stores but can not find the money to take care of public safety. Commuters shouldn't have to pay the tax of failed leadership in Marion County by leaders that commuters have no say in electing. Taxation without representation.

ADVERTISEMENT